Literature DB >> 6108932

Antifertility effects of an LH-RH analogue in male rats and dogs.

J Sandow, W von Rechenberg, C Baeder, K Engelbart.   

Abstract

The antifertility effects of a highly active LH-RH analogue, D-Ser(Bu)6-LH-RH(1-9)nonapeptide-ethylamide (buserelin) were studied in male rats and dogs. Pituitary-testicular function was not impaired by a "physiological" dose of 5 ng/rat; this dose gave reproducible LH release during chronic administration. At higher dose testicular LH receptors and responsiveness to HCG were diminished in intact prepubertal and adult rats. Pituitary inhibition was independent of gonadal or adrenal steroid feedback, and hypothalamic LH-RH as well as pituitary LH and FSH were reduced by 4 weeks treatment of castrate/adrenalectomized rats with 50 ng buserelin. In male dogs, a dose of 2.5 micrograms/kg sc reduced serum testosterone to 6% of controls within 8 weeks of treatment. Treatment was continued for 6 months and testicular involution was found to be reversible within 8 weeks of stopping treatment. LH-RH analogues at "supraphysiological" doses can be used as antifertility agents, but suppression of sexual activity in male dogs under treatment indicates that loss of libido will be a problem.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108932

Source DB:  PubMed          Journal:  Int J Fertil        ISSN: 0020-725X


  4 in total

1.  Effects of a potent LHRH-agonist on the pituitary gonadal axis with and without testosterone substitution.

Authors:  J Frick; W Aulitzky
Journal:  Urol Res       Date:  1986

Review 2.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

3.  Predominant suppression of follicle-stimulating hormone β-immunoreactivity after long-term treatment of intact and castrate adult male rats with the gonadotrophin-releasing hormone agonist deslorelin.

Authors:  A W Smith; C S Asa; B S Edwards; W J Murdoch; D C Skinner
Journal:  J Neuroendocrinol       Date:  2012-05       Impact factor: 3.627

4.  Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin).

Authors:  J P Bourguignon; G Van Vliet; M Vandeweghe; P Malvaux; M Vanderschueren-Lodeweyckx; M Craen; M V Du Caju; C Ernould
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.